LPL is the major enzyme responsible for the hydrolysis of triglyceride rich lipoproteins. The enzyme plays a major role in determining the concentration and composition of plasma lipoproteins including the LDL and HDL fractions. Therefore, understanding mechanistic aspects of LPL regulation will contribute to an understanding of atherosclerosis. In cells producing LPL a large fraction of the synthesized enzyme is degraded and degradation rate determines the net efflux of enzyme. The current proposal focuses on the molecular aspects of the function of heparan sulfate proteoglycans(HSPGs) and the low density lipoprotein receptor related protein (LRP) in the degradation of LPL> It is hypothesized that LPL on the surface of cells binds and is internalized by both HSPGs and LRP. In adipocytes, the HSPG mediated degradation predominates. We will test the notion that the core proteins of HSPGs plays a signaling function in targeting HS chains to which LPL is bound to endocytic pathways or to export to the extracellular fluid. It is also hypothesized that the LRP mediated pathway is dependent for maximal flux on HSPG binding to both LPL and LRP. Adipocyte HSPGs and tightly associated proteins will be purified, cloned, and antibodies prepared. The identification of the LPL binding domains will be completed by site directed mutagenesis, chemical modification of HSPG protected basic residues and with monoclonal antibody probes. The fraction of LPL degraded via LRP, and specific HSPGs will be quantitatively determined in pulse chase studies. RAP (Receptor-Associated Protein), X-ch-LPL-3-6a, a monoclonal antibody which inhibits LPL binding to HSPGs, phosphatidylinositol specific phospholipase C and cells devoid of HS chains will be utilized to inhibit selectively pathways of LPL degradation. Rate constants (Kon and Koff) of wild type or mutant LPL binding to LRP in the presence or absence of HS chains on cell surfaces will be determined to evaluate the function of HSPGs in the LPL/LR P interaction.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL014990-25
Application #
2668627
Study Section
Metabolism Study Section (MET)
Project Start
1976-05-01
Project End
1999-02-28
Budget Start
1998-03-01
Budget End
1999-02-28
Support Year
25
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Cornell University
Department
Nutrition
Type
Other Domestic Higher Education
DUNS #
City
Ithaca
State
NY
Country
United States
Zip Code
14850
Page, Shallee; Judson, Andrea; Melford, Kristan et al. (2006) Interaction of lipoprotein lipase and receptor-associated protein. J Biol Chem 281:13931-8
Li, Huaixing; Melford, Kristan; Judson, Andrea et al. (2004) Murine glypican-4 gene structure and expression; Sp1 and Sp3 play a major role in glypican-4 expression in 3T3-F442A cells. Biochim Biophys Acta 1679:141-55
Lutz, E Peer; Kako, Yuko; Yagyu, Hiroaki et al. (2004) Mice expressing only covalent dimeric heparin binding-deficient lipoprotein lipase: muscles inefficiently secrete dimeric enzyme. J Biol Chem 279:238-44
Rioux, Vincent; Landry, Reiko Y; Bensadoun, Andre (2002) Sandwich immunoassay for the measurement of murine syndecan-4. J Lipid Res 43:167-73
Yagyu, Hiroaki; Lutz, E Peer; Kako, Yuko et al. (2002) Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J Biol Chem 277:10037-43
Concannon, P; Levac, K; Rawson, R et al. (2001) Seasonal changes in serum leptin, food intake, and body weight in photoentrained woodchucks. Am J Physiol Regul Integr Comp Physiol 281:R951-9
Landry, R; Rioux, V; Bensadoun, A (2001) Characterization of syndecan-4 expression in 3T3-F442A mouse adipocytes: link between syndecan-4 induction and cell proliferation. Cell Growth Differ 12:497-504
Lutz, E P; Merkel, M; Kako, Y et al. (2001) Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues. J Clin Invest 107:1183-92
Sendak, R A; Berryman, D E; Gellman, G et al. (2000) Binding of hepatic lipase to heparin. Identification of specific heparin-binding residues in two distinct positive charge clusters. J Lipid Res 41:260-8
van Vlijmen, B J; Rohlmann, A; Page, S T et al. (1999) An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins. J Biol Chem 274:35219-26

Showing the most recent 10 out of 36 publications